Comparison of OK‐432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A Randomized Trial

Luhr K. T.PAN-CHYR YANGKuo S. H.Chang D. B.CHONG-JEN YULI-NA LEE2020-12-022020-12-0219920008-543Xhttps://www.scopus.com/inward/record.uri?eid=2-s2.0-0026567655&doi=10.1002%2f1097-0142%2819920201%2969%3a3%3c674%3a%3aAID-CNCR2820690313%3e3.0.CO%3b2-5&partnerID=40&md5=ab9582151c599ac631d7077f00f374f2https://scholars.lib.ntu.edu.tw/handle/123456789/524103[SDGs]SDG3Comparison of OK‐432 and mitomycin C pleurodesis for malignant pleural effusion caused by lung cancer. A Randomized Trialjournal article10.1002/1097-0142(19920201)69:3<67413096782-s2.0-0026567655